Search PubMed⌕ Search

Biomedical subjects

T Murase

Publications and source records attributed to T Murase.

At least 361 records · Page 20Linked to original sources
PubMed1987

Effect of recombinant human tumor necrosis factor on the colony growth of human leukemia progenitor cells and normal hematopoietic progenitor cells.

The effects of recombinant human tumor necrosis factor (rH-TNF) on the colony growth of human leukemia progenitor cells (L-CFU), granulocyte-macrophage progenitor cells (CFU-GM), and erythroid progenitor cells (BFU-E) were studied. L-CFU was assayed with leukemia cells obtained from patients with acute myelogenous leukemia. CFU-GM and BFU-E were assayed with bone marrow cells obtained from hematologically normal donors and patients with acute leukemia or non-Hodgkin's lymphoma in complete remission. A dose-dependent growth inhibition of L-CFU as well as CFU-GM and BFU-E was observed by rH-TNF at concentrations of 1 to 100 U/mL. The inhibitory effect on L-CFU was significantly greater than that on CFU-GM. No correlation was observed between the inhibitory effect on L-CFU and the number of colonies formed in the cultures without rH-TNF. Preincubation of the progenitor cells in culture medium containing 20% fetal calf serum with up to 1,000 U/mL of rH-TNF for 24 hours did not result in the inhibition of colony growth of L-CFU or CFU-GM. The inhibitory effect of rH-TNF was neutralized by an anti-rH-TNF murine monoclonal antibody.

Female↗
PubMed1986

Cachectin/TNF as well as interleukin-1 induces prostacyclin synthesis in cultured vascular endothelial cells.

Cachectin/tumor necrosis factor (cachectin/TNF) has been shown to be capable of stimulating prostacyclin (PGI2) production by vascular endothelial cells in vitro. The stimulation of PGI2 by cachectin/TNF is comparable to that observed with interleukin-1, the monokine previously suggested to be the principal mediator of this effect. The ability of cachectin/TNF to stimulate PGI2 production suggests that it may play a role in producing depressed blood pressure or shock. If so, it might be possible to prevent such adverse effects with the aid of anti-inflammatory agents.

6-Ketoprostaglandin F1 alpha↗
PubMed1986

Immunohistochemical localization of apolipoprotein E in atherosclerotic lesions of the aorta and coronary arteries.

The distribution of apolipoprotein E (apo E) immunoreactive substances (IRS) in atherosclerotic lesions and lesion-free areas of the aorta and coronary arteries obtained from 17 autopsied cases was studied using a specific anti-apo E serum and the unlabeled peroxidase-antiperoxidase (PAP) method. In fatty streak lesions of the aorta, many cells containing apo E-IRS were found in the deeper layer of the intima and diffuse staining of apo E in the extracellular spaces was also noted. In more advanced lesions apo E-positive cells could not be found. Immunohistochemical findings of coronary arteries differed distinctly from those of the aorta in that the apo-E-positive cells were absent in the deeper layer of the intima. The endothelial cells of coronary arteries, but not those of the aorta, showed positive staining for apo E.

Adult↗
PubMed1986

Plasma apolipoprotein CII levels in hypertriglyceridemia.

It is known that hypertriglyceridemia is associated with the elevation of plasma apolipoprotein CII (apoCII). In an attempt to look at the relationship between the two, the present study was conducted. We examined 30 patients with hypertriglyceridemia (TG, 210 to 9,127 mg/dL) and ten normolipidemic controls. Hypertriglyceridemic patients included 7 of type I hyperlipoproteinemia (HL), 17 of type IV, and 6 of type V. Plasma apoCII was measured by the single radial immunodiffusion method. Major cause for any difference in plasma apoCII could be attributed to differences in the TG-rich lipoproteins. Since a model for the lipoprotein structure indicates that TG-rich lipoproteins are spherical, with apoCII as a surface component and TG as a core substance, we calculated the square roots and the cubic roots of the values of apoCII and TG to make comparison possible. When the two variables were plotted on the X and Y axes respectively, we obtained the regression line of square root of apoCII = 0.37 X 3 the square root of TG - 0.03 with a correlation coefficient of r = .95 (P less than 0.001). The result indicates that a lipoprotein structural model accounts well for the relationship between apoCII and TG. Although a previous report suggested a compensatory increase of apoCII in lipoprotein lipase deficiency, our patients with type I HL had apoCII levels similar to those who had comparable levels of plasma TG.

Adult↗
PubMed1986

Remarkable responses of metastatic renal cell cancer in multiple organs treated with alpha-interferon.

We report a case of renal cell carcinoma with metastases in the lungs, humerus and brain, which we treated with alpha-interferon. After a transperitoneal nephrectomy the patient received a series of intramuscular injections of alpha-interferon every 2 days. Two months after the initial therapy complaints of pain in the humeral bone gradually decreased and the palpable mass in the right brachial region disappeared completely. A computerized tomography scan revealed only the scar of the intracranial metastasis. Most of the pulmonary lesions disappeared 4 months later except for the metastasis at the apex of the left lung.

Adult↗
PubMed1986

Lipoprotein lipase in mouse peritoneal macrophages: the effects of insulin and dexamethasone.

The effects of insulin and dexamethasone on the secretion of lipoprotein lipase (LPL) by mouse peritoneal macrophages were examined in vitro. Macrophages from either normal or thioglycollate-primed mice continuously secreted LPL into the culture medium. The time courses and the amounts of enzyme secretion and the responses to the hormones were essentially the same in resident or thioglycollate-primed macrophages. Insulin did not enhance the secretion of this enzyme by macrophages, even though a marked effect of this hormone on the enzyme in adipose tissue has been well established. Dexamethasone, which has been reported to stimulate the secretion of LPL in the heart, suppressed the secretion of LPL by macrophages. The present study is the first report to deal with the effect of hormones on the secretion of LPL by macrophages, and clearly demonstrates that insulin does not play an important role in the regulation of LPL activity in macrophages. Dexamethasone also showed a different effect on macrophage LPL compared to that on the enzyme in other tissues. This difference in the regulation of LPL may be relevant to the possibly different role of this enzyme in macrophages as compared to other tissues such as adipose tissue, muscle, or heart.

Animals↗
PubMed1986

Lipid metabolism in endotoxic rats: decrease in hepatic triglyceride lipase activity.

Studies were conducted to investigate the effect of E. coli endotoxin administration on hepatic triglyceride lipase (H-TGL) activity in rats, since H-TGL activity is known to behave differently from lipoprotein lipase (LPL) activity in various situations. Plasma triglyceride and free fatty acid concentrations were markedly elevated in animals after injection of endotoxin. Cholesterol and phospholipids were also increased significantly. Lipoprotein analysis by ultracentrifugation showed that the most pronounced increase of lipoproteins was in the VLDL and IDL fractions. Triglyceride lipase activities in post-heparin plasma were markedly decreased. A selective assay for H-TGL activity using a specific antibody revealed that this enzyme as well as LPL is significantly decreased (26% of control) in endotoxic animals. Thus, the increase of VLDL and IDL appears to result from the decrease of both of LPL and H-TGL.

Animals↗
PubMed1986

Behenoyl cytosine arabinoside, daunorubicin, 6-mercaptopurine, and prednisolone combination therapy for acute myelogenous leukemia in adults and prognostic factors related to remission duration and survival length.

Fifty-one consecutive previously untreated adult patients with acute myelogenous leukemia (AML) were treated with BHAC-DMP (N4-behenoyl-I-beta-D-arabinofuranosyl-cytosine, daunorubicin, 6-mercaptopurine, and prednisolone) therapy. Forty-two patients (82.4%) achieved complete remission (CR). The Kaplan-Meier analysis revealed a probability for remaining in remission of 14% and for survival of 23% at 6 years. Pretreatment factors related to the achievement of CR, such as age, French-American-British (FAB) classification and WBC at the start of treatment, were not identified. Factors related to the CR duration and survival time of the patients who had achieved CR were first analyzed by a univariate analysis with the generalized Wilcoxon test. WBC count at the start of treatment, percent of blasts in the marrow at 1 and 2 weeks after the initiation of therapy, days required until CR, number of courses of induction therapy required until CR, and days required for the disappearance of circulating blasts were identified as statistically significant prognostic factors. When these characteristics were further analyzed by the Cox multivariate regression model, the percent of blasts in the bone marrow at 2 weeks was the most important prognostic factor with a statistical significance, and WBC count at the start of treatment and days required until CR (or number of courses required to achieve CR) were also important factors, with borderline significance.

Acute Disease↗
PubMed1986

Drug metabolizing activity in rats with chronic liver injury induced by carbon tetrachloride: relationship with the content of hydroxyproline in the liver.

The drug metabolizing activity of rat liver during long-term administration of carbon tetrachloride (CCl4), and its relationship with the content of hydroxyproline (Hyp) in the liver were examined. The contents of cytochrome P-450 (P-450) and cytochrome b5 (b5) and the metabolization of aniline, aminopyrine, 7-ethoxycoumarin (7-EC) and benzo(a)pyrene (B(a)P) in the microsomal fraction were examined five days after the final administration of CCl4. The contents of P-450 and b5 and the activity to metabolize the four substrates were gradually reduced as the Hyp content in the liver increased. However, aminopyrine N-demethylation and B(a)P hydroxylation, particularly the latter, was more reduced than aniline hydroxylation and 7-EC O-deethylation in the early stage of hepatic fibrosis. Such differences may be due mainly to the different P-450 subtypes affected by CCl4.

Animals↗
PubMed1986

Effect of H2-receptor antagonists on acetaminophen-induced hepatic injury.

The effects of H2-antagonists on acetaminophen-induced hepatic injury were examined. Rats were administered acetaminophen at the dose of 800 mg/kg body, 60 hr after injection of 3-methylcholanthrene. As an H2-antagonist, cimetidine (200 mg/kg), ranitidine (50 mg or 100 mg/kg), or famotidine (20 mg or 40 mg/kg) was administered before and after acetaminophen injection. The group administered only acetaminophen had been severely damaged as evaluated by changes in serum transaminase, P-450 content, aminopyrine demethylation, glutathione content and histological study, but administration of 200 mg cimetidine together with acetaminophen significantly reduced the hepatic injury to nearly the control level. Ranitidine had no protective effect against hepatic injury at the dose of 50 mg, which appears to have the same antacid effect as 200 mg cimetidine, whereas it had a slight but significant protective effect as evaluated by the transaminase level, glutathione content and histological study at the dose of 100 mg. Famotidine had no effect against acetaminophen induced hepatic injury. Because famotidine had no effect, the protection by H2-antagonist against acetaminophen-induced hepatic injury cannot be explained by the decrease in hepatic blood flow alone. Therefore, inhibition of P-450 activity seems to be more important for reducing the generation of the reactive metabolites of acetaminophen than hepatic blood flow decrease.

Acetaminophen↗
PubMed1986

[Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer].

To clarify the relationship between the immunohistochemical distribution pattern of epithelial antigens in transitional cell carcinomas and their histopathological grading and staging, epithelial membrane antigen (EMA), carcinoembryonic antigen (CEA) and secretory component (SC) were localized. Formalin-fixed paraffin-embedded sections from 55 patients with bladder carcinoma were stained by the indirect immunoperoxidase method. In normal transitional epithelium, EMA was found on the luminal side of the plasma membrane of a few surface layers, and in the cytoplasm of the superficial cells. In the lower grade and stage of transitional cell carcinoma, only the luminal surface of superficial cells was positively stained. Membrane and cytoplasmic staining of EMA was frequently found in the intermediate and basal layers of the carcinoma, and the incidence of cytoplasmic staining increased with the higher grade and stage. CEA was not detected in normal epithelium. Cytoplasmic staining of CEA was progressively more frequent in the higher grade and stage of transitional cell carcinoma. In normal epithelium SC was observed on the apical surface plasma membrane and in the cytoplasm of the superficial cells, as shown in the immunohistochemical staining for EMA. The correlation of immunohistochemical detection of SC with the grade or stage was not as good as the correlations for EMA or CEA. These findings suggest that immunohistochemical examination for EMA, CEA and SC in bladder carcinoma could provide valuable information for grading or staging in pathological diagnosis.

Carcinoembryonic Antigen↗
PubMed1986

[A case in which alpha-interferon showed remarkable effect against the brain, bone, and lung metastases arising from the renal cell carcinoma].

A 37-year-old man was sent to our department from the Radiology Department on July 19, 1984 with the diagnosis of right renal cell carcinoma with metastases to the right humerus and bilateral lungs. He was nephrectomized immediately and administered 10 X 10(6) units of alpha-interferon i. m. every other day for 3 months during the admission and 30 X 10(6) units once a week for more than 3 months after discharge. Although in addition to humeral and lung metastases, brain metastasis was found a week after the operation, interferon showed a remarkable effect and produced get a complete response in the humeral and brain metastases, and partial response in the lung metastasis. We think this is, perhaps, the first case of CR in brain metastasis so far. We conclude that interferon can be the first choice drug as an adjuvant chemotherapy against renal cell carcinoma.

Adult↗
PubMed1986

[Rhabdomyosarcoma of the prostate].

We report a case of rhabdomyosarcoma of the prostate. The patient was a 56-year-old man who complained of anal pain and dysuria. Tumor of the prostate was suspected after rectal examination. Multiple metastatic lesions were found in the lungs and liver. A needle biopsy of the prostate revealed rhabdomyosarcoma. He received chemotherapy, using Etoposide and responded slightly. Subsequently VAC-therapy was also performed. Although the patient improved temporarily, he died 4 months after admission.

Antineoplastic Combined Chemotherapy Protocols↗